M L Davis1, H G Sparrow2, J O Ikwuagwu1, W L Musick1, K W Garey3, K K Perez4. 1. Department of Pharmacy, Houston, TX, USA. 2. Department of System Quality, Houston Methodist Hospital, Houston, TX, USA. 3. Department of Pharmacy Practice and Translational Research, University of Houston College of Pharmacy, Houston, TX, USA. Electronic address: kgarey@uh.edu. 4. Department of Pharmacy, Houston, TX, USA; Houston Methodist Research Institute, Houston, TX, USA.
Abstract
OBJECTIVES: Clostridium difficile infection (CDI) is the most common cause of healthcare-associated infections in the United States. Despite well-established risk factors, little research has focused on use of these variables to identify a patient population at high risk for CDI to target with primary prevention strategies. A predictive index for healthcare-associated CDI could improve clinical care and guide research for primary prevention trials. Our objective was to develop a predictive index to identify patients at high risk for healthcare-associated CDI. METHODS: We performed a secondary database analysis in a five-hospital health system in Houston, Texas. Our cohort consisted of 97 130 hospitalized patients admitted for more than 48 hours between October 2014 and September 2016. The derivation cohort consisted of the initial 80% of admissions (75 545 patients), with the remainder being used in the validation cohort. RESULTS: CDI rates in the derivation and validation cohorts were 1.55% and 1.43%, respectively. Thirty-day predictors of CDI were increased number of high-risk antibiotics, Charlson comorbidity index score, age and receipt of a proton pump inhibitor. These variables were incorporated into a simple risk index with a score range of 0 to 10. The final model demonstrated good discrimination and calibration with the observed CDI incidence ranging from 0.1% to 20.4%. CONCLUSIONS: We developed a predictive index for 30-day risk of healthcare-associated CDI using readily available and clinically useful variables. This simple predictive risk index may be used to improve clinical decision making and resource allocation for CDI stewardship initiatives, and guide research design.
OBJECTIVES:Clostridium difficileinfection (CDI) is the most common cause of healthcare-associated infections in the United States. Despite well-established risk factors, little research has focused on use of these variables to identify a patient population at high risk for CDI to target with primary prevention strategies. A predictive index for healthcare-associated CDI could improve clinical care and guide research for primary prevention trials. Our objective was to develop a predictive index to identify patients at high risk for healthcare-associated CDI. METHODS: We performed a secondary database analysis in a five-hospital health system in Houston, Texas. Our cohort consisted of 97 130 hospitalized patients admitted for more than 48 hours between October 2014 and September 2016. The derivation cohort consisted of the initial 80% of admissions (75 545 patients), with the remainder being used in the validation cohort. RESULTS: CDI rates in the derivation and validation cohorts were 1.55% and 1.43%, respectively. Thirty-day predictors of CDI were increased number of high-risk antibiotics, Charlson comorbidity index score, age and receipt of a proton pump inhibitor. These variables were incorporated into a simple risk index with a score range of 0 to 10. The final model demonstrated good discrimination and calibration with the observed CDI incidence ranging from 0.1% to 20.4%. CONCLUSIONS: We developed a predictive index for 30-day risk of healthcare-associated CDI using readily available and clinically useful variables. This simple predictive risk index may be used to improve clinical decision making and resource allocation for CDI stewardship initiatives, and guide research design.
Authors: Jinhee Jo; Anne J Gonzales-Luna; Chris K Lancaster; Jacob K McPherson; Khurshida Begum; M Jahangir Alam; Kevin W Garey Journal: Anaerobe Date: 2022-02-25 Impact factor: 2.837
Authors: Kelly R Reveles; Kierra M Dotson; Anne Gonzales-Luna; Dhara Surati; Bradley T Endres; M Jahangir Alam; Kevin W Garey Journal: Clin Infect Dis Date: 2019-05-17 Impact factor: 9.079
Authors: Alexandre R Marra; Eli N Perencevich; Richard E Nelson; Matthew Samore; Karim Khader; Hsiu-Yin Chiang; Margaret L Chorazy; Loreen A Herwaldt; Daniel J Diekema; Michelle F Kuxhausen; Amy Blevins; Melissa A Ward; Jennifer S McDanel; Rajeshwari Nair; Erin Balkenende; Marin L Schweizer Journal: JAMA Netw Open Date: 2020-01-03
Authors: Kevin W Garey; Khurshida Begum; Chris Lancaster; Anne Gonzales-Luna; Dinh Bui; Julie Mercier; Corinne Seng Yue; Murray P Ducharme; Ming Hu; Bradley Vince; Michael H Silverman; M Jahangir Alam; Martin Kankam Journal: J Antimicrob Chemother Date: 2020-12-01 Impact factor: 5.790